ErbB4 expression in squamous cell carcinoma of the head and neck

Targeted Oncology

Volumn 1, Issue 4, 2006, Pages 181-185

  Ben Yosef, Rami ^a   Marmor, Sylvia ^a   Starr, Alex ^a   Matceyevsky, Diana ^a   Khafif, Avi ^a   Vexler, Akiva ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ErbB4; Head and neck; Squamous cell carcinoma

Indexed keywords

EID: 33750081403     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-006-0029-y     Document Type: Article

References (13)

1. Ang KK, Andratschke NH, Milas L (2004) Epidermal growth factor receptor and response of head and neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 58:959-965
2. Craven JM, Pavelic ZP, Stambrook PJ et al (1992) Expression of c-erbB-2 gene in human head and neck carcinoma. Anticancer Res 12:2273-2276
3. Field JK, Spandidos DA, Yiagnisis M et al (1992) C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res 12:613-619
4. Beckhardt RN, Kiyokawa N, Xi L et al (1995) HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 121:1265-1270
5. Xia W, Lau YK, Zhang HZ et al (1995) Combination of EGFR, HER-2/neu and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5:4164-4174
6. de Vicente JC, Esteban I, Germana P et al (2003) Expression of ErbB-3 and ErbB-4 proto-oncogene proteins in oral squamous cell carcinoma: a pilot study. Med Oral 8:374-381
7. Klapper LN, Kirschbaum MH, Sela M et al (2000) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 77:25-79
8. Beerli RR, Hynes NE (1996) Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 271:6071-6076
9. Graus-Porta D, Beerli RR, Daly JM et al (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16:1647
10. Pinkas-Kramarski R, Shelly M, Guarino BC et al (1998) ErbB tyrosine kinases and the two neuregulin families constitute a ligand receptor network. Mol Cell Biol 18:6090-6101
11. Lonardo F, DiMarco E, King CR et al (1990) The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol 2:992-1003
12. Starr A, Greif Y, Vexler A et al (2006) ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy. Int J Cancer 119(2):269-274
13. Chen X, Levkowitz G, Tzahar E, Karunagaran D et al (1996) An immunological approach reveals biological differences between the two NDF/Heregulin receptors, ErbB-3 and ErbB-4. J Biol Chem 271:7620-7629